The aim of this study was to evaluate whether or not the expression of cAMP-phosphodiesterases (cAMP-PDE) varies in different thyroid pathologies and to elucidate the relationship between the expression of cAMP-PDE and clinic-pathologic factors. Forty thyroid biopsy samples, excised to perform the biopsy, were microscopically examined and classified. Then cAMP-PDE expression was assessed using high performance liquid chromatography. The expression of cAMP-PDE showed different patterns according to the histological features of the samples (p <0.001). A strong expression of cAMP-PDE was observed more frequently in papillar and follicular carcinoma than in controls and benign pathologies. We did not detect any level of endogenous cAMP. cAMP could be used as additional diagnostic or prognostic biomarker in patients suspected of thyroid disease, however further studies are needed to confirm these results.

CYCLIC ADENOSINE MONOPHOSHATE PHOSPHODIESTERASE: A POSSIBLE MARKER OF THYROID PATHOLOGY? / Spoto, G; D'Alessandro, L; Rubini, C; Fioroni, M; Rutjes, Aws; Spoto, S; Ferrante, M; Della Malva, M; Petrini, M. - In: JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS. - ISSN 0393-974X. - 33:1(2019), pp. 281-285.

CYCLIC ADENOSINE MONOPHOSHATE PHOSPHODIESTERASE: A POSSIBLE MARKER OF THYROID PATHOLOGY?

Rutjes, AWS;
2019

Abstract

The aim of this study was to evaluate whether or not the expression of cAMP-phosphodiesterases (cAMP-PDE) varies in different thyroid pathologies and to elucidate the relationship between the expression of cAMP-PDE and clinic-pathologic factors. Forty thyroid biopsy samples, excised to perform the biopsy, were microscopically examined and classified. Then cAMP-PDE expression was assessed using high performance liquid chromatography. The expression of cAMP-PDE showed different patterns according to the histological features of the samples (p <0.001). A strong expression of cAMP-PDE was observed more frequently in papillar and follicular carcinoma than in controls and benign pathologies. We did not detect any level of endogenous cAMP. cAMP could be used as additional diagnostic or prognostic biomarker in patients suspected of thyroid disease, however further studies are needed to confirm these results.
2019
33
1
281
285
CYCLIC ADENOSINE MONOPHOSHATE PHOSPHODIESTERASE: A POSSIBLE MARKER OF THYROID PATHOLOGY? / Spoto, G; D'Alessandro, L; Rubini, C; Fioroni, M; Rutjes, Aws; Spoto, S; Ferrante, M; Della Malva, M; Petrini, M. - In: JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS. - ISSN 0393-974X. - 33:1(2019), pp. 281-285.
Spoto, G; D'Alessandro, L; Rubini, C; Fioroni, M; Rutjes, Aws; Spoto, S; Ferrante, M; Della Malva, M; Petrini, M
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1286609
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact